Search

Becton Dickinson and Co

Geschlossen

BrancheGesundheitswesen

212.36 1.61

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

208.05

Max

214.41

Schlüsselkennzahlen

By Trading Economics

Einkommen

759M

449M

Verkäufe

269M

5B

KGV

Branchendurchschnitt

45.972

51.78

EPS

3.23

Dividendenrendite

2.12

Gewinnspanne

9.011

Angestellte

72,000

EBITDA

540M

1.2B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

-3% downside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

2.12%

1.96%

Nächstes Ergebnis

5. Nov. 2026

Nächste Dividendenausschüttung

31. Dez. 2026

Nächstes Ex-Dividendendatum

10. Dez. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

8.5B

54B

Vorheriger Eröffnungskurs

210.75

Vorheriger Schlusskurs

212.36

Becton Dickinson and Co Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Nov. 2026, 22:31 UTC

Becton Dickinson and Co is declining in after-market trading, reversing from an initial gain and falling significantly since Wednesday's close.

3. Nov. 2026, 20:36 UTC

Becton Dickinson and Co shares are declining, pulling back from an earlier session high, and are down modestly since Monday's close.

2. Nov. 2026, 22:41 UTC

Becton Dickinson and Co's shares are advancing in after-market trading, supported by a significant rise in the Health Care Equipment sub-sector.

31. Okt. 2026, 00:01 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reaching its highest level of the day and well above its 20-day moving average.

30. Okt. 2026, 21:51 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, continuing a strong performance that began shortly after the market closed.

29. Okt. 2026, 23:01 UTC

Becton Dickinson and Co shares are lower in after-market hours, reflecting broader market declines despite stronger-than-expected Q3 GDP growth.

28. Okt. 2026, 20:13 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

27. Okt. 2026, 19:16 UTC

Becton Dickinson and Co shares are declining, marking three consecutive lower daily closes, despite earlier rebounding from a session low.

26. Okt. 2026, 20:13 UTC

Becton Dickinson and Co's shares traded modestly lower during after-market hours on Monday, following a period of relative stability since the market closed.

24. Okt. 2026, 00:02 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

23. Okt. 2026, 23:21 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

22. Okt. 2026, 23:01 UTC

Becton Dickinson and Co shares fell in after-market trading, now at their lowest point of the day, moving lower since Thursday's close.

21. Okt. 2026, 19:56 UTC

Becton Dickinson and Co is experiencing a modest increase, currently positioned above its 20-day moving average and near the upper end of its one-month range.

20. Okt. 2026, 23:21 UTC

Correlated Moves

Becton Dickinson shares declined in after-market hours, influenced by disappointing earnings from holdings like Intuitive Surgical and Abbott Laboratories, amid broader sector weakness.

19. Okt. 2026, 22:21 UTC

Becton Dickinson and Co's shares rose in after-market trading, closing near session highs and reflecting a cumulative gain since Monday's close.

17. Okt. 2026, 00:01 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading following a drop shortly after Friday's close.

16. Okt. 2026, 23:11 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading, continuing a gradual decline from Friday's close while remaining above the 20-day moving average.

15. Okt. 2026, 20:02 UTC

Becton Dickinson and Co's shares are advancing amid significant gains in the Health Care Equipment sub-sector, remaining well above their 20-day moving average.

14. Okt. 2026, 23:51 UTC

Becton Dickinson shares are lower in after-market trading, reflecting a broader market decline amid renewed losses in semiconductor stocks and rising inflation concerns.

13. Okt. 2026, 19:46 UTC

Becton Dickinson and Co shares fell modestly after an early peak, reflecting typical performance for this time of day, while remaining above the 20-day moving average.

12. Okt. 2026, 22:01 UTC

Becton Dickinson and Co. shares declined modestly during after-market hours, continuing earlier losses amid unusual volatility and fluctuations in trading activity.

8. Okt. 2026, 20:01 UTC

News

Becton Dickinson advocates for reducing maternal mortality rates at the UN General Assembly, emphasizing advanced monitoring technologies for childbirth complications.

7. Okt. 2026, 19:50 UTC

News

Becton Dickinson shares fell sharply after Barclays initiated coverage with an Underweight rating and set a price target of $165, overshadowing positive trial results.

6. Okt. 2026, 21:51 UTC

News

Becton Dickinson and Co shares declined in after-market trading after Barclays initiated coverage with an Underweight rating and a $165.00 price target.

5. Okt. 2026, 20:31 UTC

Becton Dickinson and Co is experiencing a deeper decline in after-market trading, now modestly lower since Monday's close and near the lower end of its one-month range.

2. Okt. 2026, 19:26 UTC

Becton Dickinson and Co shares fell, continuing a trend of weaker closes over the past four sessions, remaining significantly below their 20-day moving average.

1. Okt. 2026, 20:07 UTC

Becton Dickinson and Co's shares fell, marking a fourth consecutive day of declines, closing below Wednesday's level and its 20-day moving average.

30. Sept. 2026, 20:20 UTC

Becton Dickinson and Co is trading modestly lower in after-market hours, continuing a decline below its recent trend and significantly under its 20-day moving average.

29. Sept. 2026, 20:07 UTC

Becton Dickinson and Co's shares are declining, reflecting a broader market trend, despite an earlier rebound from a session low.

28. Sept. 2026, 19:15 UTC

Becton Dickinson and Co shares fell slightly, trading around the midpoint of their one-month range after fluctuating earlier in the session.

Peer-Vergleich

Kursveränderung

Becton Dickinson and Co Prognose

Kursziel

By TipRanks

-3% Nachteil

12-Monats-Prognose

Durchschnitt 202.909 USD  -3%

Hoch 242 USD

Tief 165 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Becton Dickinson and Co – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

11 ratings

5

Buy

5

Halten

1

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
help-icon Live chat